Molecular Precision Mental Health

Molecular Precision Mental Health

Stacks Image 267

Scientific interests:

Lipidomics in Mental Health
Academic education:
2013 to 2016
Diploma in Biomedical Science, specialisation in Medicinal Chemistry, Ngee Ann Polytechnic, Singapore
2016 to 2018
Bachelor of Science, Major in Biomedical Science (First-class Honours), The University of Queensland, Brisbane, Australia
since 2021
PhD student, Brain and Mind Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
Professional activity:
Student intern, Lonza Biologics Tuas | Quality Assurance
2015 to 2016
Research student, Singapore General Hospital | Department of Clinical Research
2017 to 2018
Honours student, Institute for Molecular Bioscience, Alewood Group
2018 to 2021
Research Engineer, Institute of Chemical and Engineering Sciences, A'STAR
2020 to 2021
Clinical Diagnostics Technologist, Stronghold Diagnostics Laboratory, A"STAR
since 2021
PhD student, Leweke Lab, Brain and Mind Centre, The University of Sydney, Sydney, Australia


  • Allwright M, Guennewig B, Hoffmann A, Rohleder C, Jieu B, Chung LH, Jiang YC, Lemos Wimmer BF, Qi Y, Don AS, Leweke FM, Couttas TA (2024) ReTimeML: A retention time predictor that supports the LC-MS/MS analysis of sphingolipids. Sci Rep, in press
  • Couttas TA, Jieu B, Rohleder C, Leweke FM (2022) Mini Review: Current state of fluid lipid biomarkers for personalized diagnostics and therapeutics in schizophrenia spectrum disorders and related psychoses. Front Psychiatry 13:885904
  • Goggi JL, Hartimath SV, Hwang Y, Tan YX, Khanapur S, Ramasamy B, Jiang L, Yong FF, Cheng P, Tan PW, Husaini MA, Yuen TY, Jieu B, Chacko AM, Larbi A, Renia L, Johannes C, Robins EG (2020) Examining Immunotherapy Response Using Multiple Radiotracers. Mol Imaging Biol 22:993-1002
  • Goggi JL, Tan YX, Hartimath SV, Jieu B, Hwang YY, Jiang L, Boominathan R, Cheng P, Yuen TY, Chin HX, Tang JR, Larbi A, Chacko AM, Renia L, Johannes C, Robins EG (2020) Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes. Mol Imaging Biol 22:1392–1402